We also showed that treatment with SCD significantly lowered the expression of iNOS, thus indicating the anti-inflammatory exerted through both the reduced expression and enzymatic activity of iNOS that led to lower nitric oxide production. The gene discussed is NOS2; the disease is Schnyder corneal dystrophy.